Matyas R A, Mumford S L, Schliep K C, Ahrens K A, Sjaarda L A, Perkins N J, Filiberto A C, Mattison D, Zarek S M, Wactawski-Wende J, Schisterman E F
Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, MD, USA.
Risk Sciences International and University of Ottawa, Ottawa, ON, Canada.
Hum Reprod. 2015 Jul;30(7):1714-23. doi: 10.1093/humrep/dev099. Epub 2015 May 6.
Does use of commonly used over-the-counter (OTC) pain medication affect reproductive hormones and ovulatory function in premenopausal women?
Few associations were found between analgesic medication use and reproductive hormones, but use during the follicular phase was associated with decreased odds of sporadic anovulation after adjusting for potential confounders.
Analgesic medications are the most commonly used OTC drugs among women, but their potential effects on reproductive function are unclear.
STUDY DESIGN, SIZE, DURATION: The BioCycle Study was a prospective, observational cohort study (2005-2007) which followed 259 women for one (n = 9) or two (n = 250) menstrual cycles.
PARTICIPANTS, SETTING, METHODS: Two hundred and fifty-nine healthy, premenopausal women not using hormonal contraception and living in western New York state. Study visits took place at the University at Buffalo.
During study participation, 68% (n = 175) of women indicated OTC analgesic use. Among users, 45% used ibuprofen, 33% acetaminophen, 10% aspirin and 10% naproxen. Analgesic use during the follicular phase was associated with decreased odds of sporadic anovulation after adjusting for age, race, body mass index, perceived stress level and alcohol consumption (OR 0.36 [0.17, 0.75]). Results remained unchanged after controlling for potential confounding by indication by adjusting for 'healthy' cycle indicators such as amount of blood loss and menstrual pain during the preceding menstruation. Moreover, luteal progesterone was higher (% difference = 14.0, -1.6-32.1, P = 0.08 adjusted) in cycles with follicular phase analgesic use, but no associations were observed with estradiol, LH or FSH.
LIMITATIONS, REASONS FOR CAUTION: Self-report daily diaries are not validated measures of medication usage, which could lead to some classification error of medication use. We were also limited in our evaluation of aspirin and naproxen which were used by few women.
The observed associations between follicular phase analgesic use and higher progesterone and a lower probability of sporadic anovulation indicate that OTC pain medication use is likely not harmful to reproduction function, and certain medications possibly improve ovulatory function.
STUDY FUNDING/COMPETING INTERESTS: This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (contract # HHSN275200403394C). The authors have no conflicts of interest to disclose.
常用的非处方(OTC)止痛药的使用是否会影响绝经前女性的生殖激素和排卵功能?
在调整潜在混杂因素后,未发现镇痛药使用与生殖激素之间存在显著关联,但卵泡期使用镇痛药与偶发性无排卵几率降低有关。
镇痛药是女性中最常用的非处方药,但其对生殖功能的潜在影响尚不清楚。
研究设计、规模、持续时间:BioCycle研究是一项前瞻性观察队列研究(2005 - 2007年),对259名女性进行了一个(n = 9)或两个(n = 250)月经周期的随访。
参与者、研究地点、方法:259名健康的、未使用激素避孕的绝经前女性,居住在纽约州西部。研究访视在布法罗大学进行。
在研究期间,68%(n = 175)的女性表示使用了非处方镇痛药。在使用者中,45%使用布洛芬,33%使用对乙酰氨基酚,10%使用阿司匹林,10%使用萘普生。在调整年龄、种族、体重指数、感知压力水平和酒精摄入量后,卵泡期使用镇痛药与偶发性无排卵几率降低有关(OR 0.36 [0.17, 0.75])。在通过调整诸如前次月经期间的失血量和痛经等“健康”周期指标来控制潜在的指示性混杂因素后,结果保持不变。此外,在卵泡期使用镇痛药的周期中,黄体期孕酮水平较高(%差异 = 14.0,-1.6 - 32.1,经调整P = 0.08),但未观察到与雌二醇、促黄体生成素或促卵泡生成素的关联。
局限性、谨慎原因:自我报告的每日日记并非药物使用的有效验证指标,这可能导致药物使用的一些分类错误。我们对阿司匹林和萘普生的评估也受到限制,因为使用这两种药物的女性较少。
观察到的卵泡期使用镇痛药与较高孕酮水平和较低偶发性无排卵概率之间的关联表明非处方止痛药的使用可能对生殖功能无害,并且某些药物可能改善排卵功能。
研究资金/利益冲突:这项工作得到了美国国立卫生研究院尤妮斯·肯尼迪·施莱佛国家儿童健康与人类发展研究所的内部研究项目的支持(合同编号# HHSN275200403394C)。作者没有利益冲突需要披露。